GO:1900825 regulation of membrane depolarization during cardiac muscle cell action potential: Cardiac Excitability Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900825 describes any process that modulates the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
• Cardiac membrane depolarization depends on the coordinated opening of voltage-gated sodium channels and L-type calcium channels, which generate the rapid upstroke and plateau phases of the action potential.
• Beta-adrenergic signaling strongly regulates depolarization by modulating L-type Ca2+ channel activity through PKA-dependent phosphorylation.
• Dysregulation of depolarization timing underlies arrhythmogenic mechanisms, including alternans and ryanodine receptor channelopathies.
• Ion channel trafficking and membrane localization dynamically control the availability of depolarizing currents in cardiomyocytes.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal testing of genes that regulate cardiac depolarization.
Description
The Gene Ontology term GO:1900825, regulation of membrane depolarization during cardiac muscle cell action potential, defines any biological process that modulates the frequency, rate or extent of membrane depolarization in cardiac muscle cells. Membrane depolarization is the initial electrical event of the cardiac action potential, driven by the influx of positive ions that shifts the resting membrane potential toward a less negative value. This process is essential for excitation-contraction coupling and for the rhythmic propagation of electrical signals through the heart. Researchers study GO:1900825 to understand how ion channels, signaling cascades and structural proteins control cardiac excitability, and how their dysfunction contributes to arrhythmias and heart failure. Because depolarization is the trigger for every heartbeat, its regulation sits at the center of cardiac electrophysiology and translational cardiovascular research.
regulation of membrane depolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:1900825 |
|---|---|
| GO term | regulation of membrane depolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential |
| Primary ions/currents | Sodium (Na+) and calcium (Ca2+) currents that drive depolarization |
| Key channel families | Voltage-gated sodium channels, L-type calcium channels, and associated regulatory proteins |
| Cellular context | Cardiomyocyte plasma membrane, including sarcolemma and transverse tubules |
| Physiological outcome | Control of action potential upstroke and plateau, influencing excitation-contraction coupling |
What Is GO:1900825?
GO:1900825 is a biological process term that covers any mechanism that changes the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. In practical terms, it includes the modulation of ion channels and transporters that carry the depolarizing current, the signaling pathways that tune their activity, and the cellular machinery that controls their availability at the plasma membrane.
Why Is regulation of membrane depolarization during cardiac muscle cell action potential Important in Cell Biology?
Regulation of membrane depolarization during the cardiac action potential is fundamental to normal heart rhythm and contractile function. It determines the timing and amplitude of the electrical signal that triggers calcium release and contraction, and its dysregulation is directly linked to arrhythmias, alternans and inherited channelopathies. Understanding GO:1900825 helps researchers identify therapeutic targets for cardiac disease and interpret how genetic variants alter electrical behavior.
• Controls the upstroke and plateau phases of the cardiac action potential, which are required for coordinated contraction.
• Integrates beta-adrenergic signaling to adjust heart rate and contractility under stress.
• Dysregulation contributes to cardiac alternans, a precursor of lethal arrhythmias.
• Mutations in ryanodine receptors and associated proteins cause arrhythmogenic channelopathies.
• Ion channel trafficking to the plasma membrane dynamically regulates depolarization capacity.
• Provides a mechanistic framework for interpreting genetic variants in cardiac channel genes.
• Supports drug discovery by defining targets that modulate depolarization without disrupting repolarization.
• Enables CRISPR-based disease modeling of inherited arrhythmia syndromes.
What Happens During regulation of membrane depolarization during cardiac muscle cell action potential?
Initiation of depolarization by sodium current
In simple terms: The heart cell membrane suddenly becomes permeable to sodium ions, causing a rapid electrical spike.
In cardiac muscle cells, the rapid upstroke of the action potential is initiated by the opening of voltage-gated sodium channels, which allow a large influx of Na+ ions and rapidly depolarize the membrane. This phase is tightly regulated by channel availability, gating properties and membrane potential, and any modulation of these parameters directly affects the rate and extent of depolarization.
Contribution of L-type calcium current to the plateau
In simple terms: Calcium channels open more slowly and keep the cell depolarized, creating the plateau phase.
Following the initial sodium-driven upstroke, L-type Ca2+ channels activate and carry a sustained inward current that maintains the plateau phase of the action potential. The amplitude and kinetics of this calcium current are major determinants of the duration and extent of depolarization, and they are regulated by phosphorylation and interacting proteins.
Adrenergic modulation of depolarizing currents
In simple terms: Stress hormones make the heart beat faster and stronger by changing how ion channels work.
Beta-adrenergic stimulation activates PKA, which phosphorylates L-type Ca2+ channels and other targets, increasing calcium current and modulating the depolarization profile. This regulation allows the heart to adapt to increased demand but also creates a substrate for arrhythmias when excessive.
Calcium-induced calcium release and feedback
In simple terms: The calcium that enters during depolarization triggers more calcium release inside the cell, which affects electrical activity.
Calcium entering through L-type channels triggers ryanodine receptor-mediated calcium release from the sarcoplasmic reticulum, a process essential for contraction. This calcium cycling can feed back on membrane potential and depolarization timing, and its disruption leads to alternans and arrhythmogenic events.
Membrane trafficking and channel availability
In simple terms: Ion channels must be delivered to the cell surface to work, and their movement is regulated.
The number of functional ion channels at the plasma membrane is dynamically controlled by trafficking, internalization and scaffolding proteins. This regulation determines the available pool of depolarizing channels and thus modulates the frequency and extent of depolarization during the action potential.
Key Genes Involved in GO:1900825 regulation of membrane depolarization during cardiac muscle cell action potential
The following genes and proteins are central to the regulation of membrane depolarization during the cardiac muscle cell action potential, based on their established roles in cardiac electrophysiology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Voltage-gated sodium channel alpha subunit carrying the rapid depolarizing current | Mutations cause Brugada syndrome and other arrhythmias; key target for depolarization studies |
| CACNA1C | L-type calcium channel alpha-1C subunit contributing to plateau depolarization | Modulated by beta-adrenergic signaling; linked to Timothy syndrome |
| CACNB2 | L-type calcium channel beta subunit regulating channel trafficking and gating | Modifies calcium current and depolarization; candidate for arrhythmia risk |
| RYR2 | Ryanodine receptor mediating sarcoplasmic reticulum calcium release | Channelopathies cause catecholaminergic polymorphic ventricular tachycardia |
| ATP2A2 | SERCA2 calcium pump controlling calcium reuptake and cycling | Affects calcium homeostasis and electrical stability |
| FGF13 | Fibroblast growth factor homologous factor regulating sodium channel and gap junction trafficking | Modulates impulse propagation and depolarization independently of sodium channel gating |
| GJA1 | Connexin43 gap junction protein mediating electrical coupling | Regulates propagation and indirectly depolarization timing |
| PKP2 | Plakophilin-2 desmosomal protein influencing sodium current and membrane stability | Linked to arrhythmogenic cardiomyopathy and depolarization abnormalities |
| ANK2 | Ankyrin-B scaffolding protein organizing ion channels at the membrane | Mutations cause cardiac arrhythmia syndromes |
| SNTA1 | Syntrophin alpha-1 anchoring sodium channels and signaling proteins | Modulates sodium current and depolarization |
| SCN1B | Sodium channel beta-1 subunit regulating channel gating and trafficking | Modifies depolarization and arrhythmia susceptibility |
| CALM1 | Calmodulin regulating calcium channel and ryanodine receptor activity | Mutations cause long QT and CPVT syndromes |
| PRKACA | Protein kinase A catalytic subunit mediating adrenergic phosphorylation | Central to beta-adrenergic regulation of depolarizing currents |
| PPP1R1A | Protein phosphatase 1 regulatory subunit modulating channel phosphorylation | Counterbalances kinase effects on depolarization |
| CAMK2D | Calcium/calmodulin-dependent kinase II regulating calcium channels and ryanodine receptors | Contributes to arrhythmogenic calcium handling |
| NOS1 | Neuronal nitric oxide synthase modulating local redox and channel function | Influences depolarization and arrhythmia risk |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel contributing to pacemaker depolarization | Relevant to spontaneous depolarization in pacemaker cells |
How Is regulation of membrane depolarization during cardiac muscle cell action potential Regulated?
Regulation of membrane depolarization during the cardiac action potential is controlled by multiple signaling pathways. Beta-adrenergic stimulation via PKA phosphorylation enhances L-type calcium current and modulates depolarization. Calcium/calmodulin-dependent kinase II and protein phosphatases provide additional layers of control. Ion channel trafficking and scaffolding proteins dynamically adjust the available channels at the membrane, and fibroblast growth factor homologous factors such as FGF13 influence channel localization and impulse propagation.
regulation of membrane depolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, conduction disease | Knockout or point-mutation cardiomyocytes to assess depolarization kinetics |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in of patient mutations in iPSC-derived cardiomyocytes |
| CACNA1C | Timothy syndrome, long QT syndrome | Overexpression or knock-in of mutant channels in cardiac cell lines |
| FGF13 | Arrhythmia and conduction defects | Knockout models to study sodium channel and gap junction trafficking |
| PKP2 | Arrhythmogenic cardiomyopathy | Knockout or knock-in to evaluate membrane stability and depolarization |
Arrhythmogenic channelopathies
Mutations in genes encoding ion channels and calcium-handling proteins disrupt depolarization regulation and cause inherited arrhythmia syndromes. Ryanodine receptor channelopathies lead to catecholaminergic polymorphic ventricular tachycardia through aberrant calcium release that affects membrane potential. Similarly, sodium and calcium channel mutations alter the depolarization profile and increase susceptibility to lethal arrhythmias.
Cardiac alternans and sudden cardiac death
Cardiac alternans, an alternation in action potential duration and depolarization on a beat-to-beat basis, is a well-established precursor of ventricular fibrillation. Abnormal intracellular calcium cycling and impaired depolarization regulation contribute to alternans, making GO:1900825 a key process for understanding sudden cardiac death risk.
Heart failure and electrical remodeling
In heart failure, electrical remodeling alters ion channel expression and function, leading to prolonged depolarization and increased arrhythmia risk. Changes in channel trafficking and beta-adrenergic signaling further destabilize depolarization regulation. Experimental models of heart failure are used to study these changes and to test therapies targeting depolarization.
From regulation of membrane depolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter depolarization rate? | CRISPR knockout in iPSC-derived cardiomyocytes or HL-1 cells |
| Does a specific point mutation change channel gating? | CRISPR point mutation knock-in in cardiac cell lines |
| Does a disease-associated variant affect depolarization? | Knock-in of the variant in iPSC-derived cardiomyocytes |
| Where and when is a channel protein expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a signaling protein modulate depolarization? | CRISPR overexpression or lentiviral overexpression in cardiomyocytes |
| Which genes regulate depolarization in a high-throughput manner? | CRISPR library screening with voltage-sensitive dyes or calcium indicators |
How to Study the regulation of membrane depolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Action potential and ionic currents | Direct assessment of depolarization in single cells |
| Optical mapping | Action potential propagation and timing | Multicellular arrhythmia studies |
| Calcium imaging | Intracellular calcium transients | Coupling of depolarization to calcium release |
| Voltage-sensitive dyes | Membrane potential changes | High-throughput screening of depolarization modulators |
| CRISPR screening | Gene function at scale | Discovery of regulators of depolarization |
| RNA-seq | Gene expression profiles | Identification of ion channel and signaling changes |
| Proteomics | Protein abundance and interactions | Mapping channel complexes and post-translational modifications |
| Immunofluorescence | Protein localization | Assessment of channel trafficking to the membrane |
Patch-clamp electrophysiology
Patch-clamp recordings directly measure action potentials and ionic currents in cardiomyocytes, providing the gold standard for assessing depolarization parameters such as upstroke velocity and threshold. This method is used to test how genetic manipulations affect depolarization regulation.
Optical mapping and voltage-sensitive dyes
Optical mapping with voltage-sensitive dyes enables non-invasive measurement of action potential propagation and depolarization timing in multicellular preparations. It is particularly useful for studying alternans and arrhythmia mechanisms.
Calcium imaging
Fluorescent calcium indicators reveal intracellular calcium transients that are tightly coupled to depolarization and can be used to infer changes in depolarization regulation. This approach is often combined with electrophysiology.
CRISPR screening and transcriptomics
CRISPR library screening coupled with voltage or calcium reporters allows unbiased identification of genes that regulate depolarization. Transcriptomic and proteomic analyses complement these screens by revealing expression changes in ion channels and signaling proteins.
How CRISPR Can Be Used to Study GO:1900825 regulation of membrane depolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of candidate genes in cardiomyocytes or cardiac cell lines allows researchers to determine whether a gene is required for normal depolarization. For example, knocking out FGF13 disrupts sodium channel and gap junction trafficking, altering impulse propagation. Knockout studies provide causal evidence for gene function in GO:1900825.
Point Mutation
CRISPR point mutation introduces specific disease-associated variants to test their effect on depolarization. This is particularly valuable for ion channel genes where single amino acid changes can alter gating or regulation. Point-mutation models help link genotype to electrophysiological phenotype.
Knock-in
Knock-in of reporter tags or patient mutations enables precise tracking of channel localization and function. Tagged knock-in models can reveal trafficking defects that affect depolarization. Disease-variant knock-in in iPSC-derived cardiomyocytes is a powerful platform for studying arrhythmia mechanisms.
Overexpression
CRISPR overexpression or lentiviral overexpression of signaling proteins or channels can test gain-of-function effects on depolarization. Overexpressing beta-adrenergic signaling components, for instance, can mimic stress conditions that modulate depolarization. This approach is useful for validating therapeutic targets.
How EDITGENE Supports regulation of membrane depolarization during cardiac muscle cell action potential Research
Researchers studying regulation of membrane depolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in setting the depolarization threshold, upstroke velocity or plateau duration. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cardiac cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of membrane depolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About regulation of membrane depolarization during cardiac muscle cell action potential
What is GO:1900825?
GO:1900825 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
What genes are involved in regulation of membrane depolarization during cardiac muscle cell action potential?
Key genes include SCN5A, CACNA1C, CACNB2, RYR2, ATP2A2, FGF13, GJA1, PKP2, ANK2 and others that control ion channel function and trafficking.
How is cardiac membrane depolarization regulated?
It is regulated by voltage-gated sodium and calcium channels, beta-adrenergic signaling, calcium cycling and membrane trafficking of ion channels.
Why is regulation of depolarization important for heart function?
It determines the timing and strength of the electrical signal that triggers contraction, and its disruption causes arrhythmias and heart failure.
What diseases are linked to abnormal depolarization regulation?
Arrhythmogenic channelopathies, cardiac alternans, Brugada syndrome, Timothy syndrome and catecholaminergic polymorphic ventricular tachycardia are linked to abnormal depolarization.
How can CRISPR help study GO:1900825?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes that regulate depolarization in cardiomyocytes.
What methods measure depolarization in cardiomyocytes?
Patch-clamp electrophysiology, optical mapping with voltage-sensitive dyes and calcium imaging are standard methods.
What is the role of calcium in cardiac depolarization?
Calcium influx through L-type channels sustains the plateau phase and triggers calcium-induced calcium release, which feeds back on electrical activity.
How does beta-adrenergic signaling affect depolarization?
It activates PKA, which phosphorylates L-type calcium channels and other targets, increasing calcium current and modulating depolarization.
Can ion channel trafficking affect depolarization?
Yes, the number of channels at the plasma membrane is dynamically regulated, and trafficking defects alter depolarization capacity.
Conclusion
GO:1900825 captures the regulatory processes that shape membrane depolarization during the cardiac action potential, a central event in cardiac electrophysiology. Its molecular basis involves ion channels, calcium cycling, signaling kinases and trafficking machinery, and its dysfunction is implicated in arrhythmias and heart failure. CRISPR-based models and advanced electrophysiological methods provide powerful tools to dissect these mechanisms and identify therapeutic targets.
References
- 1. Gilbert G et al.. 2020. Calcium Signaling in Cardiomyocyte Function.. Cold Spring Harb Perspect Biol 12(3) PMID: 31308143
- 2. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 3. Papa A et al.. 2022. Adrenergic Regulation of Calcium Channels in the Heart.. Annu Rev Physiol 84:285-306 PMID: 34752709
- 4. Edwards JN et al.. 2014. Cardiac alternans and intracellular calcium cycling.. Clin Exp Pharmacol Physiol 41(7):524-32 PMID: 25040398
- 5. Zhao YT et al.. 2015. Arrhythmogenic mechanisms in ryanodine receptor channelopathies.. Sci China Life Sci 58(1):54-8 PMID: 25480325
- 6. Benitah JP et al.. 2010. L-type Ca(2+) current in ventricular cardiomyocytes.. J Mol Cell Cardiol 48(1):26-36 PMID: 19660468
- 7. Balse E et al.. 2012. Dynamic of ion channel expression at the plasma membrane of cardiomyocytes.. Physiol Rev 92(3):1317-58 PMID: 22811429
- 8. Liu C et al.. 2026. Fangchinoline alleviates hypertensive heart failure via PGC-1α/STAT6/PPARγ activation of mitophagy against ferroptosis.. Br J Pharmacol 183(18):5541-5565 PMID: 42380054
